Connor, Clark & Lunn Investment Management (CC&L)
PRVB

Connor, Clark & Lunn Investment Management (CC&L)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-27,864
Closed -$157K – 1272
2021
Q4 		$157K Sell
27,864
-20,619
-43% -$116K ﹤0.01% 1004
2021
Q3 		$310K Buy
+48,483
New +$310K ﹤0.01% 868